Hunter Kellerman
2024
Rate of dupilumab use and symptom severity of patients with chronic rhinosinusitis with nasal polyposis after Draf 3 frontal sinusotomy
2024 • Keven Seung Yong Ji, Hunter Kellerman, Jess C. Mace, Timothy L. Smith, Kara Y. Detwiller, Shyam Joshi, Mathew Geltzeiler
Open Author Page
Exploring foci of
2024-08-07
Rate of dupilumab use and symptom severity of patients with chronic rhinosinusitis with nasal polyposis after Draf 3 frontal sinusotomy
2024-08-07 • Keven Seung Yong Ji, Hunter Kellerman, Jess C. Mace, Timothy L. Smith, Kara Y. Detwiller, Shyam Joshi, Mathew Geltzeiler
Abstract Background The indications for endoscopic modified Lothrop procedure (Draf 3) in patients with refractory chronic rhinosinusitis with nasal polyposis (CRSwNP) remain unclear. This study evaluates the effectiveness of Draf 3 for refractory CRSwNP focusing on improvements in disease severity and need for subsequent dupilumab rescue therapy. Methods Retrospective review of patients with CRSwNP undergoing Draf 3 surgery at a tertiary center between 2012 and 2022. Clinicodemographic variables were compared acr…
Open Article Page
Glomerular Filtration Rate
First-Rate
Exchange Rate
Effective Interest Rate
U.S. Prime Rate
Rate Equation
Fixed Exchange Rate System
List Of Countries By Intentional Homicide Rate
Bit Error Rate
Open Article Page